Responsible Antimicrobial Manufacturing A Must For UK’s Subscription Model Applicants

 
• By Eliza Slawther
  
Generate a summary of this article
Listen to this article
Beta

The UK will require all antibiotic manufacturers looking to apply for funding under its subscription payment model to demonstrate they are meeting waste discharge standards in a bid to reduce antimicrobial resistance.

AMR petri dish
• Source: Shutterstock

Under the UK government’s expanded subscription-style model for antimicrobials, successful companies could be awarded payments of up to £20m ($25m) for novel antibiotics based on their value to the National Health Service (NHS) – but only those that can demonstrate compliance with responsible manufacturing standards will be considered.

Key Takeaways 

  • Applicants to the UK’s subscription payment model for antimicrobials must be BSI Kitemark certified to demonstrate their commitment to minimizing AMR.

Companies looking to apply to the scheme, which has been likened to Netflix due to the subscription-style payments it makes,...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By Saba Afreen

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     
    • By Anabel Costa-Ferreira and Ian Schofield

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography